Back to Agenda
Spotlight Symposia: Pragmatic Innovation in Clinical Trials: Broader Access, Better Evidence, and Faster Approvals
Session Chair(s)
Clario
United States
As the clinical trial landscape continues to evolve in the wake of COVID-19, now is the time to accelerate the transformation of patients' lives by unlocking better evidence through pragmatic innovation. The pandemic uncovered challenges, such as patient access, that lead to delays in start-up and delivery. Hear from leading experts as they discuss future trends and how smart drug developers can leverage technology to bring new innovations to market faster than ever before.
Speaker(s)
Madeline Geday
Madeline Geday
Astellas, United States
Senior Director, DCT Office/COE Patient Centriity
Dan Gebow, PhD
Dan Gebow, PhD
Bioclinica, United States
Chief Innovation Officer
Elisa Cascade, MBA
Elisa Cascade, MBA
Advarra, United States
Chief Product Officer
Andrew-John Mills
Andrew-John Mills
Lokavant, United States
Executive Vice President, Global Sales
Otis Johnson
Otis Johnson
Clario, United States
Chief Diversity, Inclusion & Sustainability Officer
Have an account?